The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic value of serum Cytokeratin19-2G2 in primary breast cancer patients.
Xiaoming Xie
No relevant relationships to disclose
Yana Kong
No relevant relationships to disclose
Shuqin Dai
No relevant relationships to disclose
Wanli Liu
No relevant relationships to disclose
Weidong Wei
No relevant relationships to disclose